Figure 7: The restoration of anti-fibrotic activity of NK cells is associated with improved liver fibrosis in LC patients.

Long-term observation of clinical parameters (a), including Child-Pugh scores, TBIL, ALB and HBV load; several key markers of NK cells (b), including NK percentages and the expression of CD38, NKp46 and TRAIL on total NK cells; and NK killing capacity against LX-2 cells (c), indicated by apoptosis and death of HSCs in LC patients accepting antiviral treatment. Each dot represents one individual. *P < 0.05, two-tailed, paired Student’s t-test.